Veracyte Inc (VCYT)
38.94
-0.26
(-0.66%)
USD |
NASDAQ |
Nov 21, 16:00
38.95
+0.01
(+0.03%)
After-Hours: 20:00
Veracyte Price to Book Value: 2.567 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.583 |
| November 19, 2024 | 2.580 |
| November 18, 2024 | 2.419 |
| November 15, 2024 | 2.368 |
| November 14, 2024 | 2.441 |
| November 13, 2024 | 2.605 |
| November 12, 2024 | 2.52 |
| November 11, 2024 | 2.563 |
| November 08, 2024 | 2.404 |
| November 07, 2024 | 2.461 |
| November 06, 2024 | 2.411 |
| November 05, 2024 | 2.368 |
| November 04, 2024 | 2.305 |
| November 01, 2024 | 2.261 |
| October 31, 2024 | 2.223 |
| October 30, 2024 | 2.306 |
| October 29, 2024 | 2.265 |
| October 28, 2024 | 2.248 |
| October 25, 2024 | 2.176 |
| October 24, 2024 | 2.160 |
| October 23, 2024 | 2.138 |
| October 22, 2024 | 2.148 |
| October 21, 2024 | 2.182 |
| October 18, 2024 | 2.269 |
| October 17, 2024 | 2.261 |
| Date | Value |
|---|---|
| October 16, 2024 | 2.288 |
| October 15, 2024 | 2.245 |
| October 14, 2024 | 2.236 |
| October 11, 2024 | 2.242 |
| October 10, 2024 | 2.126 |
| October 09, 2024 | 2.103 |
| October 08, 2024 | 2.206 |
| October 07, 2024 | 2.232 |
| October 04, 2024 | 2.164 |
| October 03, 2024 | 2.172 |
| October 02, 2024 | 2.227 |
| October 01, 2024 | 2.183 |
| September 30, 2024 | 2.243 |
| September 27, 2024 | 2.290 |
| September 26, 2024 | 2.273 |
| September 25, 2024 | 2.262 |
| September 24, 2024 | 2.288 |
| September 23, 2024 | 2.324 |
| September 20, 2024 | 2.362 |
| September 19, 2024 | 2.391 |
| September 18, 2024 | 2.290 |
| September 17, 2024 | 2.328 |
| September 16, 2024 | 2.281 |
| September 13, 2024 | 2.233 |
| September 12, 2024 | 2.063 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.017
Minimum
May 11 2022
12.90
Maximum
Feb 09 2021
3.201
Average
1.976
Median
Price to Book Value Benchmarks
| Fonar Corp | 0.6108 |
| XWELL Inc | 1.217 |
| ProPhase Labs Inc | 0.4821 |
| Applied DNA Sciences Inc | 0.1318 |
| OncoCyte Corp | 4.594 |
Price to Book Value Related Metrics
| PS Ratio | 6.948 |
| Price to Free Cash Flow | 52.32 |
| Price | 38.94 |
| Earnings Yield | -0.39% |
| Market Cap | 3.019B |
| Operating PE Ratio | 268.74 |
| Normalized PE Ratio | 162.77 |